AllistairAbrahamMD
Pediatric Hematology & Oncology • Washington, DCAssistant Professor, Pediatrics, George Washington University Sch of Med and Health Sciences
Are you Dr. Abraham?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 92 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
111 Michigan Ave Nw
Washington, DC 20010Phone+1 202-476-6690- Is this information wrong?
Summary
- Dr. Allistair Abraham, MD is a pediatric hematologist/oncologist in Washington, District of Columbia. He is currently licensed to practice medicine in District of Columbia, Virginia, and Tennessee. He is affiliated with Children's National Hospital and is an Assistant Professor at George Washington University Sch of Med and Health Sciences.
Education & Training
University of TennesseeFellowship, Pediatric Hematology/Oncology, 2008 - 2011
University of Miami/Jackson Health SystemResidency, Pediatrics, 2005 - 2008
Georgetown University School of MedicineClass of 2005
Certifications & Licensure
VA State Medical License 2012 - 2022
DC State Medical License 2012 - 2022
TN State Medical License 2008 - 2012
Clinical Trials
- Bone Marrow Transplantation in Young Adults With Severe Sickle Cell Disease Start of enrollment: 2012 Mar 01
- Minimizing Toxicity in HLA-identical Related Donor Transplantation for Children With Sickle Cell Disease Start of enrollment: 2018 Apr 17
- Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis Start of enrollment: 2018 Jan 24
Publications & Presentations
PubMed
- Strategic infection prevention after genetically modified hematopoietic stem cell therapies: recommendations from the International Society for Cell & Gene Therapy Ste...Tami D John, Gabriela Maron, Allistair Abraham, Alice Bertaina, Senthil Velan Bhoopalan, Alan Bidgoli, Carmem Bonfim, Zane Coleman, Amy DeZern, Jingjing Li, Chrystal L...> ;Cytotherapy. 2024 Feb 20
- Engineering the best transplant outcome for high-risk acute myeloid leukemia: the donor, the graft and beyond.Belbachir, S., Sharma, A., DeZern, A., Bonfim, C., Li, J., Ruggeri, A., Boelens, J., Purtill, D., , Abraham, A., Prockop, S., Bidgoli, A., Bertaina, A.> ;Cytotherapy. 2023 Dec 4
- 13 citationsDefining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission.Frédéric B Piel, David C Rees, Michael R DeBaun, Obiageli Nnodu, Brigitte Ranque, Alexis A Thompson, Russell E Ware, Miguel R Abboud, Allistair Abraham, Emmanuela E Am...> ;The Lancet. Haematology. 2023 Aug 1
- Join now to see all
Press Mentions
New Clinical Trial Gives Hope to Sickle Cell PatientsSeptember 25th, 2019
Hospital Affiliations
Children's National HospitalWashington, District of Columbia
